AT128587B - Radiological procedure. - Google Patents
Radiological procedure.Info
- Publication number
- AT128587B AT128587B AT128587DA AT128587B AT 128587 B AT128587 B AT 128587B AT 128587D A AT128587D A AT 128587DA AT 128587 B AT128587 B AT 128587B
- Authority
- AT
- Austria
- Prior art keywords
- radiological procedure
- sodium
- urinary tract
- iodomethanesulfonic
- solutions
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 3
- RDFJFVXMRYVOAC-UHFFFAOYSA-N methiodal Chemical class OS(=O)(=O)CI RDFJFVXMRYVOAC-UHFFFAOYSA-N 0.000 claims description 5
- 238000012800 visualization Methods 0.000 claims 1
- 210000001635 urinary tract Anatomy 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 210000000244 kidney pelvis Anatomy 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- SSRNFOYTFWRGAC-UHFFFAOYSA-L CI.S(=O)(=O)([O-])[O-].[Na+].[Na+] Chemical compound CI.S(=O)(=O)([O-])[O-].[Na+].[Na+] SSRNFOYTFWRGAC-UHFFFAOYSA-L 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 229960003695 methiodal Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 210000000626 ureter Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
- A61K49/0452—Solutions, e.g. for injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
- A61K49/0495—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound intended for oral administration
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Description
<Desc/Clms Page number 1>
EMI1.1
Es wurde gefunden, dass man Hohlsysteme des Körpers, wie z. B. Blutgefässe, Gelenkhöhlen, Fisteln, die Harnwege u. dgl., röntgenologisch zur Darstellung bringen kann, indem man diese Hohlsysteme mit Lösungen von jodmethansulfosauren Salzen auffüllt. Zur Sichtbarmachung der Harnwege kann man auch so verfahren, dass man das jodmethansulfosaure Salz bzw. seine Lösungen dem Organismus auf einem der dafür üblichen Wege zuführt und die Zeit, während der das jodmethansulfosaure Salz mit dem Harn ausgeschieden wird, zur Röntgenaufnahme ausnutzt. Bei den in üblicher Weise durchgeführten röntgenographischen Aufnahmen erhält man ein naturgetreues Bild der betreffenden aufgefüllten Hohlorgane. Das beschriebene Verfahren stellt daher eine bemerkenswerte Bereicherung der Röntgentechnik dar.
Beispiel l : Einem durch entsprechende Diät vorbereiteten Menschen werden 20 g jodmethansulfosaures Natrium, in 100 em3 Wasser gelöst, innerhalb 1-2 Minuten intravenös injiziert. Wenige
EMI1.2
der Harnwege liefert.
Man kann die Aufnahme auch mehrere Stunden nach der Injektion noch durchführen.
Beispiel 2 : Ein 5 kg schwerer Hund erhält 10 < /jodmethansulfosaures Natrium, in Wasser gelöst, per os. Ein nach 30 Minuten angefertigtes Röntgenbild der Harnwege bringt dieses zur Darstellung.
Beispiel 3 : Bei einem Menschen werden mittels Ureter-Katheterismus die Nierenbecken mit 15% iger wässeriger Lösung von jodmethansulfosaurem Natrium in an sich bekannter Weise aufgefüllt.
Auf der wenig später hergestellten Röntgenaufnahme sind das Nierenbecken und die Ureteren in allen Einzelheiten sichtbar.
Ausser den vorzugsweise angewandten Natriumsalzen der Jodmethansulfosäure haben sich auch andere Salze dieser Säure mit anorganischen oder organischen Basen als brauchbar erwiesen.
**WARNUNG** Ende DESC Feld kannt Anfang CLMS uberlappen**.
<Desc / Clms Page number 1>
EMI1.1
It has been found that hollow systems of the body, such as. B. blood vessels, joint cavities, fistulas, the urinary tract and the like. Like., can be made radiologically by filling these hollow systems with solutions of iodomethanesulfonic acid salts. To make the urinary tract visible, one can also proceed in such a way that the iodomethanesulfonic acid salt or its solutions are supplied to the organism in one of the usual ways and the time during which the iodomethanesulfonic acid salt is excreted in the urine is used for X-rays. In the case of the conventional radiographic recordings, a lifelike image of the filled hollow organs in question is obtained. The method described is therefore a remarkable addition to X-ray technology.
Example 1: A person who has been prepared by an appropriate diet is injected intravenously within 1-2 minutes with 20 g of sodium iodomethane sulfate dissolved in 100 cubic meters of water. Few
EMI1.2
the urinary tract supplies.
You can still record several hours after the injection.
Example 2: A dog weighing 5 kg receives 10% sodium iodomethanesulfate, dissolved in water, orally. An X-ray of the urinary tract made after 30 minutes shows this.
Example 3: In a person, the renal pelvis is filled with a 15% aqueous solution of sodium iodomethanesulfate in a manner known per se by means of ureteral catheterism.
The renal pelvis and ureters are visible in every detail on the x-ray taken a little later.
In addition to the sodium salts of iodomethanesulfonic acid which are preferably used, other salts of this acid with inorganic or organic bases have also proven to be useful.
** WARNING ** End of DESC field may overlap beginning of CLMS **.
Claims (1)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE647244T | 1930-06-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AT128587B true AT128587B (en) | 1932-06-10 |
Family
ID=6580954
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT128587D AT128587B (en) | 1930-06-10 | 1931-06-09 | Radiological procedure. |
Country Status (5)
| Country | Link |
|---|---|
| AT (1) | AT128587B (en) |
| CH (1) | CH161431A (en) |
| DE (1) | DE647244C (en) |
| DK (1) | DK48099C (en) |
| NL (1) | NL31804C (en) |
-
1930
- 1930-06-10 DE DE1930647244D patent/DE647244C/en not_active Expired
-
1931
- 1931-06-08 DK DK48099D patent/DK48099C/en active
- 1931-06-09 NL NL57214A patent/NL31804C/xx active
- 1931-06-09 AT AT128587D patent/AT128587B/en active
- 1931-06-09 CH CH161431D patent/CH161431A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE647244C (en) | 1937-06-30 |
| CH161431A (en) | 1933-04-30 |
| DK48099C (en) | 1933-12-04 |
| NL31804C (en) | 1934-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT128587B (en) | Radiological procedure. | |
| AT134007B (en) | Radiological procedure. | |
| AT136142B (en) | Radiological procedure. | |
| AT129942B (en) | Contrast media for fluoroscopy. | |
| DE735441C (en) | X-ray contrast media | |
| AT156940B (en) | Radiological procedure. | |
| AT148307B (en) | X-ray contrast media. | |
| CH165420A (en) | Process for obtaining a highly concentrated aqueous solution of a salt of 3,5-diiodo-2-pyridone-N-acetic acid. | |
| AT64787B (en) | Method of making a cancer cure. | |
| AT137681B (en) | Process for increasing the water solubility of halogenoxy- or -oxopyridincarboxylic or -sulfonic acids. | |
| CH168363A (en) | Radiographic contrast agent. | |
| CH163442A (en) | Process for obtaining a highly concentrated aqueous solution of a salt of 3,5-diiodo-2-pyridone-N-acetic acid. | |
| CH239111A (en) | Process for the production of a contrast substance suitable for the radiographic representation of the organs of the animal and human body. | |
| AT85026B (en) | Method of making condoms. | |
| AT133283B (en) | Process for the preparation of durable, supersaturated calcium gluconate solutions. | |
| AT60095B (en) | Process for the production of colored bodies containing selenium or tellurium for healing purposes. | |
| DE348070C (en) | Process for the preparation of metal compounds of sulfinides | |
| CH163443A (en) | Process for the production of a highly concentrated aqueous solution of a salt of 3,5-dibromo-4-pyridone-N-acetic acid. | |
| DE374097C (en) | Process for the production of double compounds from caffeine which are easily soluble in water | |
| AT129598B (en) | Process for the production of solutions of basic quinine which can be used in therapy. | |
| CH163441A (en) | Process for obtaining a highly concentrated aqueous solution of a salt of 3,5-diiodo-4-pyridone-N-acetic acid. | |
| AT151757B (en) | Process for the preparation of stable aqueous solutions of all salts present in the blood. | |
| AT133143B (en) | Process for the preparation of readily soluble sodium salts of 4-oxy-3-acylaminobenzolaric acids (1) or their substitution products. | |
| DE564211C (en) | Process for the preparation of homologous iodine methanesulfonic acids and their salts | |
| DE560887C (en) | Process for the production of cements |